MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of short-term
investments
$44,693K
Proceeds from sale of
property and equipment
$250K
Net cash provided by
investing activities
$19,772K
Canceled cashflow
$25,171K
Net decrease in cash
and cash...
-$1,326K
Canceled cashflow
$19,772K
Non-cash lease expense
$1,510K
Stock-based compensation
expense
$1,274K
Prepaid expenses
-$243K
Accounts payable and
accrued liabilities
$233K
Depreciation and
amortization
$122K
Other assets
-$80K
Amortization of financing
lease right-of-use...
$17K
Proceeds from the sale of
financing lease assets
$142K
Employee stock purchase
plan proceeds
$5K
Exercise of options into
common stock
$2K
Purchases of short-term
investments
$25,155K
Purchases of property and
equipment
$16K
Net cash used in
operating activities
-$20,453K
Canceled cashflow
$3,479K
Net cash used in
financing activities
-$645K
Canceled cashflow
$149K
Net loss
-$21,085K
Operating lease
liabilities
-$1,586K
Accretion on marketable
securities
-$699K
Compensation and employee
benefits
-$562K
Principal payments for
financing leases
$790K
Payment of employee
restricted stock tax...
$3K
Cash in lieu of
fractional shares for...
$1K
Back
Back
Cash Flow
source: myfinsight.com
Sensei Biotherapeutics, Inc. (SNSE)
Sensei Biotherapeutics, Inc. (SNSE)